Intuitive Surgical, Inc. vs Lockheed Martin Corporation — how do they compare? Intuitive Surgical, Inc. trades at $351.3 (market cap $125.08B), while Lockheed Martin Corporation trades at $507 (market cap $117.48B). The key difference: Intuitive Surgical, Inc. and Lockheed Martin Corporation are close in size by market cap, and Lockheed Martin Corporation pays a 2.71% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.
| ISRG | LMT | |
|---|---|---|
Market Cap | $125.08B | $117.48B |
Sector | Health | Industrials |
52-Week High | $592.85 | $676.70 |
52-Week Low | $345.42 | $410.74 |
Enterprise Value | $116.45B | $136.28B |
Dividend Yield | — | 2.71% |
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $350.06, down 1.34% on the day and near its 52-week low of $344.55. The stock is in a bearish technical trend despite strong fundamentals: Q2 2026 EPS beat estimates at $2.80 vs. $2.48 expected, revenue grew to $10.06B in 2025, and net income margin expanded to 28.45%. However, slowing U.S. procedure growth and a cautious 2026 outlook have pressured shares, with recent news highlighting a nearly 40% decline year-to-date.
The outlook remains mixed: robust profitability and a 69.6% analyst buy rating with a $504.56 consensus target suggest long-term value, but near-term risks include valuation concerns (P/E 40.5), competitive pressures, and macroeconomic headwinds. Investors face a divergence between solid execution and market sentiment driven by growth deceleration fears.
Lockheed Martin (LMT) trades at $507.09, down 0.33% on the day, with a bearish technical signal but strong analyst consensus. Recent earnings show mixed results with Q3 2025 beating estimates but subsequent quarters missing. The company reported 2025 revenue of $75.05B and net income of $5.02B, with a P/E of 24.68. News highlights include the launch of a lower-cost Patriot missile and collaborations in space technology, reflecting strategic moves to address cost pressures and growth opportunities.
LMT presents a bullish long-term outlook with a consensus price target of $614, representing 21% upside, supported by a strong defense backlog and space economy potential. Risks include margin compression from cost-cutting initiatives, hypersonic missile delays, and competitive threats from low-cost defense startups. Investor sentiment is cautiously optimistic, balancing near-term earnings volatility against strategic positioning in high-growth defense sectors.
Trailing returns across standard periods
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →